BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Altı ay boyunca karlılık: -8.83%
Sektör: Healthcare

Promosyon programı Zydus Lifesciences Limited


Şirket hakkında

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

daha fazla ayrıntı
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

EBITDA 25.16
EV/EBITDA 14.03
ISIN INE010B01027
Industry Pharmaceuticals
P/BV 2.4
P/E 23.93
P/S 2.04
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 138.12
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Число акций ао 1.0122 млрд
Günlük fiyat değişimi: +1.37% (959.55)
Haftalık fiyat değişimi: -0.1232% (973.9)
Aylık fiyat değişimi: +2.31% (950.7)
3 ayda fiyat değişimi: -9.48% (1074.6)
Altı ayda fiyat değişimi: -8.83% (1066.95)
Yıllık fiyat değişimi: +41.75% (686.2)
3 yılda fiyat değişimi: +119.03% (444.1)
5 yılda fiyat değişimi: +332.98% (224.65)
10 yılda fiyat değişimi: 0% (972.7)
Yılbaşından bu yana fiyat değişimi: -1.55% (988)

Hafife alma

İsim Anlam Seviye
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
Toplam: 5

Yeterlik

İsim Anlam Seviye
ROA, % 14.03 4
ROE, % 20.67 7
Toplam: 4.17

Temettüler

İsim Anlam Seviye
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
Toplam: 2.58

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 37.72 5
karlılık Ebitda, % 36.84 5
karlılık EPS, % 233.73 10
Toplam: 7.2



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 yıllar)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 yıllar)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

Adres: India, Ahmedabad, Zydus Corporate Park - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://zyduslife.com